Our study highlights the anti-tumor effect of the transcription factors CREB-CBP inhibitor, NASTRp, in in vitro, through regulation of cell cycle, tumor-promoting autophagy, ER stress and cell death (Fig 6D). The gene discussed is CREBBP; the disease is neoplasm.